Siatis Perry C
Insider CIK 1951400 · ABBV EVP, GC AND SECRETARY
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ABBV AbbVie Inc. | S Sale | 2026-03-02 | 2026-03-03 | 5,777 | $233.51 | $1.35M | 17,510 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2026-03-02 | 2026-03-03 | 2,600 | $235.26 | $611.7K | 4,619 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2026-03-02 | 2026-03-03 | 10,291 | $234.66 | $2.41M | 7,219 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2026-02-27 | 2026-03-03 | 14,850 | $232.08 | $3.45M | 23,287 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2026-02-25 | 2026-02-27 | 7,292 | $192.86 | $1.41M | 14,583 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2026-02-25 | 2026-02-27 | 7,775 | $175.28 | $1.36M | 7,774 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2026-02-25 | 2026-02-27 | 7,314 | $149.62 | $1.09M | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2026-02-25 | 2026-02-27 | 22,381 | $230.00 | $5.15M | 38,137 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2026-02-25 | 2026-02-27 | 7,775 | $175.28 | $1.36M | 53,226 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2026-02-25 | 2026-02-27 | 7,314 | $149.62 | $1.09M | 45,451 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2026-02-25 | 2026-02-27 | 7,292 | $192.86 | $1.41M | 60,518 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2026-02-18 | 2026-02-20 | 19,500 | — | $0 | 19,500 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 5,792 | — | $0 | 26,701 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 5,628 | — | $0 | 32,329 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 16,290 | — | $0 | 20,909 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2026-02-18 | 2026-02-20 | 5,808 | — | $0 | 38,137 | SEC↗ |
| ABBV AbbVie Inc. | D To issuer deriv | 2025-03-03 | 2025-03-04 | 7,315 | $149.62 | $1.09M | 7,314 | SEC↗ |
| ABBV AbbVie Inc. | D To issuer deriv | 2025-03-03 | 2025-03-04 | 2,918 | $144.54 | $421.8K | 0 | SEC↗ |
| ABBV AbbVie Inc. | D To issuer deriv | 2025-03-03 | 2025-03-04 | 7,775 | $175.28 | $1.36M | 15,549 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2025-03-03 | 2025-03-04 | 7,315 | $149.62 | $1.09M | 14,852 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2025-03-03 | 2025-03-04 | 18,008 | $210.00 | $3.78M | 4,619 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2025-03-03 | 2025-03-04 | 7,775 | $175.28 | $1.36M | 22,627 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2025-03-03 | 2025-03-04 | 2,918 | $144.54 | $421.8K | 7,537 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2025-02-28 | 2025-03-04 | 2,718 | $205.38 | $558.2K | 11,793 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2025-02-28 | 2025-03-04 | 7,870 | $205.02 | $1.61M | 14,511 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2025-02-28 | 2025-03-04 | 363 | $207.19 | $75.2K | 4,619 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2025-02-28 | 2025-03-04 | 6,811 | $206.62 | $1.41M | 4,982 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2025-02-20 | 2025-02-24 | 1,784 | $197.40 | $352.2K | 26,375 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2025-02-20 | 2025-02-24 | 3,994 | $198.12 | $791.3K | 22,381 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 21,875 | — | $0 | 21,875 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 4,496 | — | $0 | 14,893 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 1,844 | — | $0 | 16,737 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 5,792 | — | $0 | 22,529 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2025-02-13 | 2025-02-18 | 5,630 | — | $0 | 28,159 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2024-02-29 | 2024-03-01 | 6,504 | $177.05 | $1.15M | 13,784 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2024-02-29 | 2024-03-01 | 3,387 | $178.04 | $603.0K | 10,397 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2024-02-28 | 2024-03-01 | 7,885 | $178.99 | $1.41M | 20,288 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2024-02-23 | 2024-02-27 | 7,315 | $149.62 | $1.09M | 14,629 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2024-02-23 | 2024-02-27 | 2,919 | $144.54 | $421.9K | 2,919 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2024-02-23 | 2024-02-27 | 3,519 | $105.92 | $372.7K | 0 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2024-02-23 | 2024-02-27 | 7,315 | $149.62 | $1.09M | 41,926 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2024-02-23 | 2024-02-27 | 2,919 | $144.54 | $421.9K | 31,092 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2024-02-23 | 2024-02-27 | 3,519 | $105.92 | $372.7K | 34,611 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2024-02-23 | 2024-02-27 | 13,753 | $177.51 | $2.44M | 28,173 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2024-02-15 | 2024-02-20 | 23,324 | — | $0 | 23,324 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 8,022 | — | $0 | 18,399 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 2,138 | — | $0 | 20,537 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 1,844 | — | $0 | 22,381 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-15 | 2024-02-20 | 5,792 | — | $0 | 28,173 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2024-02-02 | 2024-02-06 | 2,919 | $144.54 | $421.9K | 5,837 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2024-02-02 | 2024-02-06 | 2,919 | $144.54 | $421.9K | 13,296 | SEC↗ |
| ABBV AbbVie Inc. | D To issuer | 2024-02-02 | 2024-02-06 | 2,919 | $170.00 | $496.2K | 10,377 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2023-04-03 | 2023-04-05 | 3,520 | $105.92 | $372.8K | 3,520 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2023-04-03 | 2023-04-05 | 3,520 | $105.92 | $372.8K | 13,897 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-04-03 | 2023-04-05 | 3,520 | $160.00 | $563.2K | 10,377 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-03-01 | 2023-03-02 | 805 | $153.38 | $123.5K | 10,377 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-03-01 | 2023-03-02 | 11,330 | $153.06 | $1.73M | 11,182 | SEC↗ |
| ABBV AbbVie Inc. | F Tax w/h | 2023-02-28 | 2023-03-02 | 9,656 | $154.28 | $1.49M | 22,512 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise deriv | 2023-02-21 | 2023-02-22 | 7,364 | $93.50 | $688.5K | 0 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-02-21 | 2023-02-22 | 3,933 | $151.29 | $595.0K | 32,168 | SEC↗ |
| ABBV AbbVie Inc. | M Exercise | 2023-02-21 | 2023-02-22 | 7,364 | $93.50 | $688.5K | 39,532 | SEC↗ |
| ABBV AbbVie Inc. | S Sale | 2023-02-21 | 2023-02-22 | 3,431 | $150.73 | $517.2K | 36,101 | SEC↗ |
| ABBV AbbVie Inc. | A Award deriv | 2023-02-16 | 2023-02-21 | 21,944 | — | $0 | 21,944 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 2,140 | — | $0 | 30,322 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 14,437 | — | $0 | 24,814 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 3,368 | — | $0 | 28,182 | SEC↗ |
| ABBV AbbVie Inc. | A Award | 2023-02-16 | 2023-02-21 | 1,846 | — | $0 | 32,168 | SEC↗ |